IL237498B - Drug delivery systems and methods for treating bladder emptying dysfunction and other lower urinary tract disorders using tropesium - Google Patents
Drug delivery systems and methods for treating bladder emptying dysfunction and other lower urinary tract disorders using tropesiumInfo
- Publication number
- IL237498B IL237498B IL237498A IL23749815A IL237498B IL 237498 B IL237498 B IL 237498B IL 237498 A IL237498 A IL 237498A IL 23749815 A IL23749815 A IL 23749815A IL 237498 B IL237498 B IL 237498B
- Authority
- IL
- Israel
- Prior art keywords
- treatment
- methods
- drug delivery
- delivery systems
- urinary tract
- Prior art date
Links
- 208000026723 Urinary tract disease Diseases 0.000 title 1
- 238000012377 drug delivery Methods 0.000 title 1
- 230000004064 dysfunction Effects 0.000 title 1
- 238000000034 method Methods 0.000 title 1
- 208000014001 urinary system disease Diseases 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/439—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom the ring forming part of a bridged ring system, e.g. quinuclidine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/46—8-Azabicyclo [3.2.1] octane; Derivatives thereof, e.g. atropine, cocaine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0034—Urogenital system, e.g. vagina, uterus, cervix, penis, scrotum, urethra, bladder; Personal lubricants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M31/00—Devices for introducing or retaining media, e.g. remedies, in cavities of the body
- A61M31/002—Devices for releasing a drug at a continuous and controlled rate for a prolonged period of time
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/10—Drugs for disorders of the urinary system of the bladder
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- Urology & Nephrology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Biomedical Technology (AREA)
- Emergency Medicine (AREA)
- Heart & Thoracic Surgery (AREA)
- Hematology (AREA)
- Anesthesiology (AREA)
- Gynecology & Obstetrics (AREA)
- Reproductive Health (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Molecular Biology (AREA)
- Surgery (AREA)
- Vascular Medicine (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201261702576P | 2012-09-18 | 2012-09-18 | |
| PCT/US2013/060479 WO2014047221A1 (en) | 2012-09-18 | 2013-09-18 | Drug delivery systems and methods for treatment of bladder voiding dysfunction|and other lower urinary tract disorders by using trospium |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| IL237498A0 IL237498A0 (en) | 2015-04-30 |
| IL237498B true IL237498B (en) | 2018-01-31 |
Family
ID=49301639
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL237498A IL237498B (en) | 2012-09-18 | 2015-03-02 | Drug delivery systems and methods for treating bladder emptying dysfunction and other lower urinary tract disorders using tropesium |
Country Status (13)
| Country | Link |
|---|---|
| US (2) | US10500200B2 (enExample) |
| EP (1) | EP2897616A1 (enExample) |
| JP (2) | JP6600256B2 (enExample) |
| KR (1) | KR102141433B1 (enExample) |
| CN (2) | CN104684556A (enExample) |
| AU (1) | AU2013318146B2 (enExample) |
| BR (1) | BR112015005351A2 (enExample) |
| CA (1) | CA2883855C (enExample) |
| IL (1) | IL237498B (enExample) |
| MX (2) | MX379066B (enExample) |
| RU (1) | RU2670749C9 (enExample) |
| SG (1) | SG11201502104YA (enExample) |
| WO (1) | WO2014047221A1 (enExample) |
Families Citing this family (20)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US8721621B2 (en) | 2009-09-10 | 2014-05-13 | Taris Biomedical, Inc. | Systems and methods for deploying devices to genitourinary sites |
| WO2014036556A2 (en) | 2012-08-31 | 2014-03-06 | Taris Biomedical, Inc. | Drug delivery systems and methods for treatment of prostate |
| PL2890384T3 (pl) | 2012-08-31 | 2022-02-14 | Taris Biomedical Llc | Układy podawania leku i sposoby leczenia raka pęcherza obejmujące oksaliplatynę |
| EP2897616A1 (en) * | 2012-09-18 | 2015-07-29 | TARIS Biomedical LLC | Drug delivery systems and methods for treatment of bladder voiding dysfunction!and other lower urinary tract disorders by using trospium |
| PT3113782T (pt) | 2014-03-06 | 2023-01-05 | Taris Biomedical Llc | Sistemas e métodos de administração de fármaco para tratamento do cancro da bexiga com gemcitabina |
| EP3183026B1 (en) * | 2014-08-19 | 2019-10-30 | The Regents of The University of California | Implants for localized drug delivery and methods of use thereof |
| GB201506526D0 (en) | 2015-04-17 | 2015-06-03 | Uropharma Ltd And Synesis Llc | Medicinal composition |
| CN106706832A (zh) * | 2015-08-06 | 2017-05-24 | 舒泰神（北京）生物制药股份有限公司 | 一种测定曲司氯铵含量的方法 |
| CN110418658A (zh) * | 2017-02-01 | 2019-11-05 | 塔里斯生物医药公司 | 体内药物递送装置和药物递送的方法 |
| US10857173B2 (en) | 2017-07-25 | 2020-12-08 | Taris Biomedical Llc | Methods of treating tumor metastasis |
| TWI841554B (zh) | 2018-03-21 | 2024-05-11 | 丹麥商珍美寶股份有限公司 | 以鉑為主之劑與抗組織因子抗體－藥物共軛物的組合治療癌症之方法 |
| CA3099547A1 (en) | 2018-05-07 | 2019-11-14 | Reshma Abdulla RANGWALA | Methods of treating cancer with a combination of an anti-pd-1 antibody and an anti-tissue factor antibody-drug conjugate |
| AU2019315957A1 (en) * | 2018-08-01 | 2021-02-18 | Taris Biomedical Llc | Methods of treating overactive bladder using trospium |
| TWI844571B (zh) | 2018-10-30 | 2024-06-11 | 丹麥商珍美寶股份有限公司 | 使用抗血管內皮生長因子（ｖｅｇｆ）抗體與抗組織因子（ｔｆ）抗體－藥物共軛體之組合以治療癌症之方法 |
| US20220211615A1 (en) * | 2019-04-30 | 2022-07-07 | Trigone Pharma Ltd. | Formulations and methods for drug instillation into the bladder and treatment of bladder ailments |
| US11344526B2 (en) | 2020-03-20 | 2022-05-31 | The Regents Of The University Of California | Implantable drug delivery devices for localized drug delivery |
| EP4100075A4 (en) | 2020-03-20 | 2024-01-31 | The Regents of University of California | IMPLANTABLE DRUG RELEASE DEVICES FOR LOCALIZED DRUG RELEASE |
| US11338119B2 (en) | 2020-03-20 | 2022-05-24 | The Regents Of The University Of California | Implantable drug delivery devices for localized drug delivery |
| US11173291B2 (en) | 2020-03-20 | 2021-11-16 | The Regents Of The University Of California | Implantable drug delivery devices for localized drug delivery |
| KR102596697B1 (ko) | 2021-05-20 | 2023-11-01 | 김정우 | 바위솔 추출물을 유효성분으로 포함하는 화장품 조성물 및 그 제조 방법 |
Family Cites Families (22)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ATE172117T1 (de) * | 1996-11-27 | 1998-10-15 | Pfleger R Chem Fab | Verwendung von trospiumchlorid zur herstellung eines arzneimittels zur behandlung von blasenkrankheiten |
| EP1424079A1 (en) * | 2002-11-27 | 2004-06-02 | Boehringer Ingelheim International GmbH | Combination of a beta-3-receptor agonist and of a reuptake inhibitor of serotonin and/or norepinephrine |
| US20060058777A1 (en) * | 2002-12-11 | 2006-03-16 | Pia Norup Nielsen | Urinary catheter device with a pharmaceutically active composition |
| AU2004206846B2 (en) | 2003-01-16 | 2009-05-28 | University Of Rochester | Quaternary antimuscarinic compounds for the treatment of bladder diseases |
| DE602004020337D1 (de) | 2004-08-11 | 2009-05-14 | Boehringer Ingelheim Pharma | Anticholinergika enthaltende Arzneimittel zur Behandlung von Krankheiten der ableitenden Harnwege |
| US20060217405A1 (en) * | 2005-03-17 | 2006-09-28 | Indevus Pharmaceuticals, Inc. | Interstitial cystitis treatment |
| US7390816B2 (en) | 2005-06-21 | 2008-06-24 | Bridge Pharma, Inc. | Methods for treating urinary incontinence in patients suffering from memory disorders |
| EP1933810B1 (en) | 2005-08-11 | 2012-10-10 | Massachusetts Institute of Technology | Intravesical drug delivery device and method |
| EP1967202A1 (en) | 2007-03-05 | 2008-09-10 | AEterna Zentaris GmbH | Use of LHRH Antagonists for the Treatment of Lower Urinary Tract Symptoms, in particular Overactive Bladder and/or Detrusor Overactivity |
| EA201070703A1 (ru) | 2007-12-11 | 2010-12-30 | Массачусетс Инститьют Оф Текнолоджи | Имплантируемое устройство для доставки лекарства и способы лечения мочевого пузыря и других полостей тела или трубчатых органов |
| EA201170297A1 (ru) | 2008-08-09 | 2011-08-30 | Массачусетс Инститьют Оф Текнолоджи | Имплантируемое устройство для доставки лекарственных средств и способ лечения мужской мочеполовой системы и окружающих тканей |
| CA2765630C (en) | 2009-06-26 | 2016-07-05 | Taris Biomedical, Inc. | Solid drug tablets for implantable drug delivery devices |
| US9017312B2 (en) | 2009-09-10 | 2015-04-28 | Taris Biomedical Llc | Implantable device for controlled drug delivery |
| US8721621B2 (en) | 2009-09-10 | 2014-05-13 | Taris Biomedical, Inc. | Systems and methods for deploying devices to genitourinary sites |
| AU2010339821B2 (en) | 2009-12-17 | 2015-02-19 | Taris Biomedical Llc | Implantable device with intravesical tolerability and methods of treatment |
| US20110218488A1 (en) | 2010-03-05 | 2011-09-08 | Taris Biomedical, Inc. | Systems and Methods for Implanting Devices in the Bladder and Other Genitourinary Sites |
| WO2012048104A1 (en) | 2010-10-06 | 2012-04-12 | Taris Biomedical, Inc. | Implantable drug delivery device with bladden retention feature |
| WO2012048114A1 (en) * | 2010-10-06 | 2012-04-12 | Taris Biomedical, Inc. | Time-selective bioresorbable or collapsible drug delivery systems and methods |
| JP2014503554A (ja) | 2011-01-10 | 2014-02-13 | タリス バイオメディカル，インコーポレイテッド | 膀胱痛及び刺激性排尿の持続的治療の使用のためのリドカインレジメン |
| ES2637388T3 (es) * | 2011-02-04 | 2017-10-13 | Taris Biomedical, Inc. | Dispositivo implantable para la liberación controlada de un fármaco de baja solubilidad |
| EP2897616A1 (en) * | 2012-09-18 | 2015-07-29 | TARIS Biomedical LLC | Drug delivery systems and methods for treatment of bladder voiding dysfunction!and other lower urinary tract disorders by using trospium |
| PL2968880T3 (pl) | 2013-03-15 | 2025-06-23 | Taris Biomedical Llc | Urządzenia do dostarczania leku ze składnikiem przepuszczalnym dla leku |
-
2013
- 2013-09-18 EP EP13771696.5A patent/EP2897616A1/en active Pending
- 2013-09-18 WO PCT/US2013/060479 patent/WO2014047221A1/en not_active Ceased
- 2013-09-18 MX MX2015003110A patent/MX379066B/es unknown
- 2013-09-18 CN CN201380046758.2A patent/CN104684556A/zh active Pending
- 2013-09-18 RU RU2015112196A patent/RU2670749C9/ru active
- 2013-09-18 CN CN202010161062.6A patent/CN111450093A/zh active Pending
- 2013-09-18 CA CA2883855A patent/CA2883855C/en active Active
- 2013-09-18 BR BR112015005351A patent/BR112015005351A2/pt not_active Application Discontinuation
- 2013-09-18 JP JP2015532177A patent/JP6600256B2/ja active Active
- 2013-09-18 AU AU2013318146A patent/AU2013318146B2/en not_active Ceased
- 2013-09-18 SG SG11201502104YA patent/SG11201502104YA/en unknown
- 2013-09-18 KR KR1020157008403A patent/KR102141433B1/ko active Active
-
2015
- 2015-03-02 IL IL237498A patent/IL237498B/en active IP Right Grant
- 2015-03-11 MX MX2020002465A patent/MX2020002465A/es unknown
- 2015-03-16 US US14/658,699 patent/US10500200B2/en active Active
-
2018
- 2018-02-02 JP JP2018017300A patent/JP2018080208A/ja active Pending
-
2019
- 2019-12-06 US US16/706,009 patent/US11850244B2/en active Active
Also Published As
| Publication number | Publication date |
|---|---|
| CA2883855A1 (en) | 2014-03-27 |
| RU2670749C9 (ru) | 2018-12-13 |
| MX2015003110A (es) | 2015-06-05 |
| US11850244B2 (en) | 2023-12-26 |
| MX2020002465A (es) | 2020-07-13 |
| WO2014047221A9 (en) | 2015-05-21 |
| IL237498A0 (en) | 2015-04-30 |
| CN104684556A (zh) | 2015-06-03 |
| WO2014047221A1 (en) | 2014-03-27 |
| BR112015005351A2 (pt) | 2017-07-04 |
| KR20150058271A (ko) | 2015-05-28 |
| JP6600256B2 (ja) | 2019-10-30 |
| US20150182516A1 (en) | 2015-07-02 |
| AU2013318146B2 (en) | 2018-05-10 |
| JP2018080208A (ja) | 2018-05-24 |
| MX379066B (es) | 2025-03-04 |
| RU2670749C2 (ru) | 2018-10-25 |
| US20200108057A1 (en) | 2020-04-09 |
| AU2013318146A1 (en) | 2015-03-19 |
| US10500200B2 (en) | 2019-12-10 |
| JP2015529688A (ja) | 2015-10-08 |
| RU2015112196A (ru) | 2016-11-10 |
| SG11201502104YA (en) | 2015-05-28 |
| CA2883855C (en) | 2020-09-15 |
| CN111450093A (zh) | 2020-07-28 |
| EP2897616A1 (en) | 2015-07-29 |
| KR102141433B1 (ko) | 2020-08-05 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL237498A0 (en) | Drug delivery systems and methods for treating bladder emptying dysfunction and other lower urinary tract disorders using tropesium | |
| PT2600800T (pt) | Dispositivo de administração de drogas por stent ureteral, kit e método | |
| EP2528648A4 (en) | CATHETER DEVICES AND DRAINAGE SYSTEMS FOR THE DELIVERY OF THERAPEUTIC AGENTS | |
| EP2785275A4 (en) | TREATMENT OF HARNINE CONTINENCE | |
| EP2413917A4 (en) | DRUG DELIVERY SYSTEM AND METHODS OF USING THE SAME | |
| IL239557A0 (en) | Microarray for providing therapeutic material and methods for use | |
| IL227576A0 (en) | Highlighting materials in mri, transfer and extraction systems, and methods of production and use thereof | |
| EP2675402A4 (en) | BLOOD FLOW INTERFERENCE DEVICES AND METHOD FOR THE TREATMENT OF VASCULAR DEFECTS | |
| EP2782631A4 (en) | IMPLANTABLE APPARATUS FOR USE IN THE ADMINISTRATION OF A SOLID-LIQUID MEDICAMENT, ASSOCIATED FORMULATIONS AND METHODS OF USE | |
| IL237281B (en) | Drug delivery systems and methods for treating bladder cancer comprising oxaliplatin | |
| IL227312A0 (en) | Lidocaine administration regimen for long-term treatment of bladder pain and voiding irritation | |
| IL237300A0 (en) | Drug delivery systems and methods for treating prostate gland diseases containing gemcitabine | |
| EP2553639A4 (en) | SYSTEMS AND METHODS FOR MANAGING THE TREATMENT OF ORPHAN DISEASE | |
| IL254446A0 (en) | Implantable drug delivery preparations and treatment methods thereof | |
| ZA201400348B (en) | Catheter,particularly an indwelling catheter,for treating functional problems and/or diseases of the bladder and/or prostate | |
| EP2755686A4 (en) | METHODS AND SYSTEMS FOR MANUFACTURING MICRO-TABLETS FOR USE IN THE DELIVERY OF MEDICAMENTS | |
| ME03438B (me) | DERIVAT 2-ACILAMINOTIAZOLA ZA UPOTREBU U PREVENCIJI ILI LEčENJU OBOLJENJA BESIKE / URINARNOG TRAKTA | |
| PT2774991T (pt) | Sistema de entrega de fármaco para utilização no tratamento ou diagnóstico de distúrbios neurológicos | |
| EP2790637A4 (en) | VAGINAL DRUG DELIVERY DEVICES AND METHODS OF MANUFACTURING THE SAME | |
| ZA201502288B (en) | Ciclesonide for treatment of airway disease in horses | |
| IL223175A (en) | Indian Tamar seed polysaccharide for use in the treatment of inflammatory diseases | |
| IL239308A0 (en) | Treatment of diseases of endothelial dysfunction and inflammation | |
| EP2673372A1 (en) | Methods of prognosing and administering treatment for inflammatory disorders | |
| EP2640468A4 (en) | ADMINISTRATIVE AND TREATMENT PROCEDURES | |
| IL227921A0 (en) | Methods for prognosis and treatment of inflammatory disorders |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FF | Patent granted | ||
| KB | Patent renewed | ||
| KB | Patent renewed |